NO161679C - Analogifremgangsm te ved fremstilling av terapeutisk aktive steroider. - Google Patents

Analogifremgangsm te ved fremstilling av terapeutisk aktive steroider.

Info

Publication number
NO161679C
NO161679C NO843406A NO843406A NO161679C NO 161679 C NO161679 C NO 161679C NO 843406 A NO843406 A NO 843406A NO 843406 A NO843406 A NO 843406A NO 161679 C NO161679 C NO 161679C
Authority
NO
Norway
Prior art keywords
preparation
therapeutic active
active steroids
analogy procedure
analogy
Prior art date
Application number
NO843406A
Other languages
English (en)
Norwegian (no)
Other versions
NO843406L (no
NO161679B (no
Inventor
Jean-Marie Cassal
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO843406L publication Critical patent/NO843406L/no
Publication of NO161679B publication Critical patent/NO161679B/no
Publication of NO161679C publication Critical patent/NO161679C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO843406A 1983-08-25 1984-08-24 Analogifremgangsm te ved fremstilling av terapeutisk aktive steroider. NO161679C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH464483 1983-08-25

Publications (3)

Publication Number Publication Date
NO843406L NO843406L (no) 1985-02-26
NO161679B NO161679B (no) 1989-06-05
NO161679C true NO161679C (no) 1989-09-13

Family

ID=4279973

Family Applications (1)

Application Number Title Priority Date Filing Date
NO843406A NO161679C (no) 1983-08-25 1984-08-24 Analogifremgangsm te ved fremstilling av terapeutisk aktive steroider.

Country Status (21)

Country Link
US (1) US4680290A (da)
EP (1) EP0135762B1 (da)
JP (1) JPS6061595A (da)
KR (1) KR850001767A (da)
AR (1) AR240834A1 (da)
AT (1) ATE37883T1 (da)
AU (1) AU574706B2 (da)
CA (1) CA1252778A (da)
DE (1) DE3474552D1 (da)
DK (1) DK347584A (da)
ES (2) ES8602844A1 (da)
FI (1) FI842830A7 (da)
GR (1) GR80196B (da)
HU (1) HU189929B (da)
IL (1) IL72725A (da)
MC (1) MC1618A1 (da)
NO (1) NO161679C (da)
NZ (1) NZ209275A (da)
PH (1) PH19849A (da)
PT (1) PT79130B (da)
ZA (1) ZA846430B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1241947A (en) * 1985-05-31 1988-09-13 Pierre R. Proulx Conjugated polyene sterol derivatives as membrane probes
US5026882A (en) * 1988-12-23 1991-06-25 Smithkline Beecham Corporation Phosphinic acid substituted steroids as inhibitors of steroid 5α-reductase
US4946834A (en) * 1988-12-23 1990-08-07 Smithkline Beecham Corporation Phosphonic acid substituted steroids as steroid 5α-reductase inhibitors
US5215972A (en) * 1989-11-22 1993-06-01 Hoffmann-La Roche Inc. Steroids
CA2028759A1 (en) * 1989-11-22 1991-05-23 Jean-Marie Cassal Steroids
US5244887A (en) * 1992-02-14 1993-09-14 Straub Carl D Stanols to reduce cholesterol absorption from foods and methods of preparation and use thereof
JPH10509976A (ja) * 1994-11-30 1998-09-29 アムール リサーチ コーポレーション ホスホコリン薬物誘導体
CA2223179A1 (en) * 1995-06-07 1996-12-19 Bob Dale Brown Phosphonic acid-based cationic lipids
JPH11507352A (ja) 1995-06-07 1999-06-29 ジンタ・インコーポレイテッド 新規カルバメート基本カチオン性脂質
JP2002514183A (ja) * 1996-09-17 2002-05-14 スーパージェン・インコーポレーテッド リン脂質薬剤誘導体
US5830432A (en) * 1997-03-31 1998-11-03 Amur Pharmacuticals, Inc. Phospholipid drug derivatives
CA2330611A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
US6794375B2 (en) 2000-01-28 2004-09-21 The Procter & Gamble Co. Palatable arginine compounds and uses thereof for cardiovascular health
US20030045473A1 (en) * 2002-07-19 2003-03-06 Sarama Robert Joseph Compositions, kits, and methods for cardiovascular health
SI1889198T1 (sl) 2005-04-28 2015-02-27 Proteus Digital Health, Inc. Farma-informacijski sistem
WO2007035716A2 (en) 2005-09-16 2007-03-29 Raptor Pharmaceutical Inc. Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
JP2010511648A (ja) * 2006-12-08 2010-04-15 ジャド テクノロジーズ ゲーエムベーハー 感染性疾患の治療及び予防のためのコレステリルアミン
DK2398500T3 (da) 2009-02-20 2019-05-13 2 Bbb Medicines B V Glutathion-baseret lægemiddelafgivelsessystem
SG175896A1 (en) 2009-05-06 2011-12-29 Lab Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
EP4452323A4 (en) * 2021-12-20 2025-12-17 Ohio State Innovation Foundation COMPOSITIONS CONTAINING STEROL AMINO PHOSPHATE COMPOUNDS AND METHOD FOR THEIR PREPARATION AND USE

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3248408A (en) * 1963-07-22 1966-04-26 Merck & Co Inc Purification of steroid phosphates

Also Published As

Publication number Publication date
EP0135762B1 (de) 1988-10-12
ATE37883T1 (de) 1988-10-15
ZA846430B (en) 1985-04-24
ES535391A0 (es) 1985-12-01
EP0135762A2 (de) 1985-04-03
DK347584D0 (da) 1984-07-13
PT79130B (en) 1986-11-14
DK347584A (da) 1985-02-26
ES8606879A1 (es) 1986-05-01
GR80196B (en) 1985-01-02
NZ209275A (en) 1987-06-30
AU574706B2 (en) 1988-07-14
CA1252778A (en) 1989-04-18
NO843406L (no) 1985-02-26
PT79130A (en) 1984-09-01
US4680290A (en) 1987-07-14
KR850001767A (ko) 1985-04-01
AR240834A2 (es) 1991-02-28
ES8602844A1 (es) 1985-12-01
FI842830A7 (fi) 1985-02-26
AR240834A1 (es) 1991-02-28
IL72725A0 (en) 1984-11-30
JPS6061595A (ja) 1985-04-09
MC1618A1 (fr) 1985-07-18
HUT34997A (en) 1985-05-28
FI842830A0 (fi) 1984-07-13
AU3222584A (en) 1985-02-28
IL72725A (en) 1988-07-31
EP0135762A3 (en) 1986-01-22
DE3474552D1 (en) 1988-11-17
PH19849A (en) 1986-07-22
NO161679B (no) 1989-06-05
ES543646A0 (es) 1986-05-01
HU189929B (en) 1986-08-28

Similar Documents

Publication Publication Date Title
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO158021C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt d-fenylalanyl-l-prolyl-l-argininaldehydsulfat.
NO156693C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-propynylsteroider.
NO165239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater.
NO161679C (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive steroider.
NO165192C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO166320C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO162858C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive thiazolidinderivater.
NO156525C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive (3-aminopropoksy)bibenzylderivater.
NO167510C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenylkinolincarboxylsyrer
NO158183C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylfenylamidiner.
NO163693C (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser av platina.
NO161676C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive mitosanderivater.
NO159528C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoguanidinderivater.
NO161562C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO159086C (no) Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt triazolderivat.
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO161559C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater.
NO831588L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive 4-aryl-4-piperidincarbinoler
NO158941C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
NO157976C (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive 3-fenoxy-1-azetidincarboxamider.
NO160000C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive forbindelser.
NO161177C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive tioetere.
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO160511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater.